317 related articles for article (PubMed ID: 7507183)
21. Viral activation from latency during retrodifferentiation of U937 cells exposed to phorbol ester followed by infection with human immunodeficiency virus type 1.
Okada Y; Kimura T; Kameoka M; Kishi M; Azuma I; Ikuta K
Immunopharmacology; 1995 Jun; 30(1):27-39. PubMed ID: 7591711
[TBL] [Abstract][Full Text] [Related]
22. Production of infectious particles from defective human immunodeficiency virus type 1 (HIV-1)-producing cell clones by superinfection with infectious HIV-1.
Yunoki M; Maotani-Imai K; Kusuda H; Motoyama M; Miyake S; Imai H; Shin YS; Kato S; Sano K; Morita C
Arch Virol; 1991; 116(1-4):143-58. PubMed ID: 2001175
[TBL] [Abstract][Full Text] [Related]
23. 5' long terminal repeat (LTR)-selective methylation of latently infected HIV-1 provirus that is demethylated by reactivation signals.
Ishida T; Hamano A; Koiwa T; Watanabe T
Retrovirology; 2006 Oct; 3():69. PubMed ID: 17034647
[TBL] [Abstract][Full Text] [Related]
24. Genetic analysis of human immunodeficiency virus type 1 integrase and the U3 att site: unusual phenotype of mutants in the zinc finger-like domain.
Masuda T; Planelles V; Krogstad P; Chen IS
J Virol; 1995 Nov; 69(11):6687-96. PubMed ID: 7474078
[TBL] [Abstract][Full Text] [Related]
25. Single-cell RNA sequencing reveals common and unique gene expression profiles in primary CD4+ T cells latently infected with HIV under different conditions.
Zhang X; Qazi AA; Deshmukh S; Lobato Ventura R; Mukim A; Beliakova-Bethell N
Front Cell Infect Microbiol; 2023; 13():1286168. PubMed ID: 38156317
[TBL] [Abstract][Full Text] [Related]
26. Establishment of novel cell lines latently infected with human immunodeficiency virus 1.
Oh YT; Kim KC; Hong KJ; Lee HS; Jang DH; Lee JS; Choi SY; Kim SS; Choi BS
Acta Virol; 2011; 55(2):155-9. PubMed ID: 21692564
[TBL] [Abstract][Full Text] [Related]
27. A nonproducer, interfering human immunodeficiency virus (HIV) type 1 provirus can be transduced through a murine leukemia virus-based retroviral vector: recovery of an anti-HIV mouse/human pseudotype retrovirus.
Federico M; Nappi F; Ferrari G; Chelucci C; Mavilio F; Verani P
J Virol; 1995 Nov; 69(11):6618-26. PubMed ID: 7474070
[TBL] [Abstract][Full Text] [Related]
28. A lentiviral vector that activates latent human immunodeficiency virus-1 proviruses by the overexpression of tat and that kills the infected cells.
Macías D; Oya R; Saniger L; Martín F; Luque F
Hum Gene Ther; 2009 Nov; 20(11):1259-68. PubMed ID: 19604078
[TBL] [Abstract][Full Text] [Related]
29. The Pathway To Establishing HIV Latency Is Critical to How Latency Is Maintained and Reversed.
Rezaei SD; Lu HK; Chang JJ; Rhodes A; Lewin SR; Cameron PU
J Virol; 2018 Jul; 92(13):. PubMed ID: 29643247
[TBL] [Abstract][Full Text] [Related]
30. Chromatin maturation of the HIV-1 provirus in primary resting CD4+ T cells.
Lindqvist B; Svensson Akusjärvi S; Sönnerborg A; Dimitriou M; Svensson JP
PLoS Pathog; 2020 Jan; 16(1):e1008264. PubMed ID: 31999790
[TBL] [Abstract][Full Text] [Related]
31. Interleukin-10 enhances tumor necrosis factor-alpha activation of HIV-1 transcription in latently infected T cells.
Rabbi MF; Finnegan A; Al-Harthi L; Song S; Roebuck KA
J Acquir Immune Defic Syndr Hum Retrovirol; 1998 Dec; 19(4):321-31. PubMed ID: 9833740
[TBL] [Abstract][Full Text] [Related]
32. Interferon-alpha but not AZT suppresses HIV expression in chronically infected cell lines.
Poli G; Orenstein JM; Kinter A; Folks TM; Fauci AS
Science; 1989 May; 244(4904):575-7. PubMed ID: 2470148
[TBL] [Abstract][Full Text] [Related]
33. Cell surface CD4 downregulation and resistance to superinfection induced by a defective provirus of HIV-1.
Little SJ; Riggs NL; Chowers MY; Fitch NJ; Richman DD; Spina CA; Guatelli JC
Virology; 1994 Dec; 205(2):578-82. PubMed ID: 7975260
[TBL] [Abstract][Full Text] [Related]
34. Heme arginate potentiates latent HIV-1 reactivation while inhibiting the acute infection.
Shankaran P; Vlkova L; Liskova J; Melkova Z
Antiviral Res; 2011 Dec; 92(3):434-46. PubMed ID: 22001321
[TBL] [Abstract][Full Text] [Related]
35. Nef protein of human immunodeficiency virus type 1: evidence against its role as a transcriptional inhibitor.
Hammes SR; Dixon EP; Malim MH; Cullen BR; Greene WC
Proc Natl Acad Sci U S A; 1989 Dec; 86(23):9549-53. PubMed ID: 2687884
[TBL] [Abstract][Full Text] [Related]
36. Inhibition of HIV type 1 replication in chronically infected monocytes and lymphocytes by retrovirus-mediated gene transfer of anti-Rev single-chain variable fragments.
Ho WZ; Lai JP; Bouhamdan M; Duan L; Pomerantz RJ; Starr SE
AIDS Res Hum Retroviruses; 1998 Nov; 14(17):1573-80. PubMed ID: 9840290
[TBL] [Abstract][Full Text] [Related]
37. Soluble tumor necrosis factor receptors inhibit phorbol myristate acetate and cytokine-induced HIV-1 expression chronically infected U1 cells.
Granowitz EV; Saget BM; Angel JB; Wang MZ; Wang A; Dinarello CA; Skolnik PR
J Acquir Immune Defic Syndr Hum Retrovirol; 1996 Apr; 11(5):430-7. PubMed ID: 8605587
[TBL] [Abstract][Full Text] [Related]
38. Cells nonproductively infected with HIV-1 exhibit an aberrant pattern of viral RNA expression: a molecular model for latency.
Pomerantz RJ; Trono D; Feinberg MB; Baltimore D
Cell; 1990 Jun; 61(7):1271-6. PubMed ID: 2364429
[TBL] [Abstract][Full Text] [Related]
39. Contribution of Vpu, Env, and Nef to CD4 down-modulation and resistance of human immunodeficiency virus type 1-infected T cells to superinfection.
Wildum S; Schindler M; Münch J; Kirchhoff F
J Virol; 2006 Aug; 80(16):8047-59. PubMed ID: 16873261
[TBL] [Abstract][Full Text] [Related]
40. Jurkat-Derived (J-Lat, J1.1, and Jurkat E4) and CEM-Derived T Cell Lines (8E5 and ACH-2) as Models of Reversible Proviral Latency.
Rodari A; Poli G; Van Lint C
Methods Mol Biol; 2022; 2407():3-15. PubMed ID: 34985653
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
